Stocktoria

Playboy, Inc. PLBY

Nasdaq · stock · Retail-Miscellaneous Retail · website · IPO 2020-06-01

Playboy, Inc. statistics & valuation

Market cap$156.6M
P / S1.3×
P / B8.5×
Net margin-10.5%
FCF margin-0.8%
Net debt$136.4M
Enterprise value USD$292.9M
Earnings yield EBIT/EV-2.7%
Return on capital-3.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-3.60% -31.50% -149.70% -126.20% -68.40% -10.50% 202020212022202320242025
Gross margin (%)
61.70% 64.00% 71.00% 202020212022202320242025
Operating margin (%)
9.20% -27.90% -159.60% -133.20% -43.80% -6.60% 202020212022202320242025
Return on equity (%)
-6.30% -18.40% -178.90% -393.10% -69.00% 202020212022202320242025
Shares outstanding
22.2M 42.3M 47.4M 72.5M 89.9M 112.8M 202020212022202320242025
Net debt ($)
$151.5M $159.6M $161.4M $162.3M $145.7M $136.4M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-1.30% -8.30% -50.10% -54.00% -27.90% -4.30% 202020212022202320242025
Free cash flow margin (%)
0.00% -22.00% -38.50% -32.80% -18.40% -0.80% 202020212022202320242025
Debt / equity (×)
1.99× 0.54× 1.24× 4.15× 9.48× 202020212022202320242025
EPS ($)
-$0.24 -$2.04 -$5.86 -$2.53 -$1.04 -$0.13 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin71.0%64.0%61.7%
Operating margin-6.6%-43.8%-133.2%-159.6%-27.9%9.2%
Net margin-10.5%-68.4%-126.2%-149.7%-31.5%-3.6%
FCF margin-0.8%-18.4%-32.8%-38.5%-22.0%-0.0%
Return on assets-4.3%-27.9%-54.0%-50.1%-8.3%-1.3%
Return on equity-69.0%1027.0%-393.1%-178.9%-18.4%-6.3%
Debt / equity9.48×-22.84×4.15×1.24×0.54×1.99×
Current ratio1.031.031.181.301.180.87

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.